News
Dupilumab-associated lymphoid reactions require caution
- Author:
- John Jesitus
In cases involving unexpected responses or atypical presentations, clinicians must have a low threshold for stopping dupilumab.
News

Guillain-Barré syndrome: Honing treatment strategies
- Author:
- John Jesitus
Classic subtypes of Guillain-Barré syndrome are varying manifestations of a shared disease process, novel insights into the disease indicate. This...
News

NPF provides guidance for virtual psoriasis visits
- Author:
- John Jesitus
A National Psoriasis Foundation position paper addresses ongoing management of psoriatic disease via telemedicine.
News

Pooled safety data analysis of tralokinumab reported
- Author:
- John Jesitus
Regarding safety areas of special interest, eye disorders classified as conjunctivitis, keratoconjunctivitis, or keratitis occurred more commonly...
News

NRS grants target rosacea’s underlying mechanisms
- Author:
- John Jesitus
The National Rosacea Society has funded studies to examine rosacea mechanisms via sequencing technology and by looking at lasers’ impact.
News

Serum dupilumab levels do not predict clinical response
- Author:
- John Jesitus
In a study of adults with eczema, dupilumab blood levels at 4 months bore no correlation with clinical responses or adverse events during the...